The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1396
August 6, 2012
View Complete Issue         Table of Contents 2019 
Ivermectin (Sklice) Topical Lotion for Head Lice
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Ivermectin (Sklice) Topical Lotion for Head Lice
August 6, 2012 (Issue: 1396)
The FDA has approved the antiparasitic drug ivermectin in a 0.5% lotion (Sklice – Sanofi Pasteur) as a single-use topical treatment for head lice in patients ≥6 months old. Oral ivermectin (Stromectol – Merck) is effective for treatment of...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Ivermectin (Sklice) Topical Lotion for Head Lice
Article code: 1396b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.